502 related articles for article (PubMed ID: 11948135)
1. Tumor-specific regulation of angiogenic growth factors and their receptors during recovery from cytotoxic therapy.
Taylor AP; Osorio L; Craig R; Raleigh JA; Ying Z; Goldenberg DM; Blumenthal RD
Clin Cancer Res; 2002 Apr; 8(4):1213-22. PubMed ID: 11948135
[TBL] [Abstract][Full Text] [Related]
2. Upregulation of vascular endothelial growth factor (VEGF) and downregulation of placenta growth factor (PlGF) associated with malignancy in human thyroid tumors and cell lines.
Viglietto G; Maglione D; Rambaldi M; Cerutti J; Romano A; Trapasso F; Fedele M; Ippolito P; Chiappetta G; Botti G
Oncogene; 1995 Oct; 11(8):1569-79. PubMed ID: 7478581
[TBL] [Abstract][Full Text] [Related]
3. Upregulation of the angiogenic factors PlGF, VEGF and their receptors (Flt-1, Flk-1/KDR) by TSH in cultured thyrocytes and in the thyroid gland of thiouracil-fed rats suggest a TSH-dependent paracrine mechanism for goiter hypervascularization.
Viglietto G; Romano A; Manzo G; Chiappetta G; Paoletti I; Califano D; Galati MG; Mauriello V; Bruni P; Lago CT; Fusco A; Persico MG
Oncogene; 1997 Nov; 15(22):2687-98. PubMed ID: 9400995
[TBL] [Abstract][Full Text] [Related]
4. Expression of angiogenesis stimulators and inhibitors in human thyroid tumors and correlation with clinical pathological features.
Bunone G; Vigneri P; Mariani L; Butó S; Collini P; Pilotti S; Pierotti MA; Bongarzone I
Am J Pathol; 1999 Dec; 155(6):1967-76. PubMed ID: 10595926
[TBL] [Abstract][Full Text] [Related]
5. Altered tumor vessel maturation and proliferation in placenta growth factor-producing tumors: potential relationship to post-therapy tumor angiogenesis and recurrence.
Taylor AP; Rodriguez M; Adams K; Goldenberg DM; Blumenthal RD
Int J Cancer; 2003 Jun; 105(2):158-64. PubMed ID: 12673673
[TBL] [Abstract][Full Text] [Related]
6. Flt-1 but not KDR/Flk-1 tyrosine kinase is a receptor for placenta growth factor, which is related to vascular endothelial growth factor.
Sawano A; Takahashi T; Yamaguchi S; Aonuma M; Shibuya M
Cell Growth Differ; 1996 Feb; 7(2):213-21. PubMed ID: 8822205
[TBL] [Abstract][Full Text] [Related]
7. Microtumor growth initiates angiogenic sprouting with simultaneous expression of VEGF, VEGF receptor-2, and angiopoietin-2.
Vajkoczy P; Farhadi M; Gaumann A; Heidenreich R; Erber R; Wunder A; Tonn JC; Menger MD; Breier G
J Clin Invest; 2002 Mar; 109(6):777-85. PubMed ID: 11901186
[TBL] [Abstract][Full Text] [Related]
8. Modulation of the angiogenesis response through Ha-ras control, placenta growth factor, and angiopoietin expression in mouse skin carcinogenesis.
Larcher F; Franco M; Bolontrade M; Rodriguez-Puebla M; Casanova L; Navarro M; Yancopoulos G; Jorcano JL; Conti CJ
Mol Carcinog; 2003 Jun; 37(2):83-90. PubMed ID: 12766907
[TBL] [Abstract][Full Text] [Related]
9. Regulation by vascular endothelial growth factor of human colon cancer tumorigenesis in a mouse model of experimental liver metastasis.
Warren RS; Yuan H; Matli MR; Gillett NA; Ferrara N
J Clin Invest; 1995 Apr; 95(4):1789-97. PubMed ID: 7535799
[TBL] [Abstract][Full Text] [Related]
10. Placental defects in ARNT-knockout conceptus correlate with localized decreases in VEGF-R2, Ang-1, and Tie-2.
Abbott BD; Buckalew AR
Dev Dyn; 2000 Dec; 219(4):526-38. PubMed ID: 11084652
[TBL] [Abstract][Full Text] [Related]
11. Hypoxia-inducible factor-1 mediates activation of cultured vascular endothelial cells by inducing multiple angiogenic factors.
Yamakawa M; Liu LX; Date T; Belanger AJ; Vincent KA; Akita GY; Kuriyama T; Cheng SH; Gregory RJ; Jiang C
Circ Res; 2003 Oct; 93(7):664-73. PubMed ID: 12958144
[TBL] [Abstract][Full Text] [Related]
12. Tumor-derived vascular endothelial growth factor up-regulates angiopoietin-2 in host endothelium and destabilizes host vasculature, supporting angiogenesis in ovarian cancer.
Zhang L; Yang N; Park JW; Katsaros D; Fracchioli S; Cao G; O'Brien-Jenkins A; Randall TC; Rubin SC; Coukos G
Cancer Res; 2003 Jun; 63(12):3403-12. PubMed ID: 12810677
[TBL] [Abstract][Full Text] [Related]
13. Two independent mechanisms essential for tumor angiogenesis: inhibition of human melanoma xenograft growth by interfering with either the vascular endothelial growth factor receptor pathway or the Tie-2 pathway.
Siemeister G; Schirner M; Weindel K; Reusch P; Menrad A; Marmé D; Martiny-Baron G
Cancer Res; 1999 Jul; 59(13):3185-91. PubMed ID: 10397264
[TBL] [Abstract][Full Text] [Related]
14. Hemochorial placentation in the primate: expression of vascular endothelial growth factor, angiopoietins, and their receptors throughout pregnancy.
Wulff C; Wilson H; Dickson SE; Wiegand SJ; Fraser HM
Biol Reprod; 2002 Mar; 66(3):802-12. PubMed ID: 11870089
[TBL] [Abstract][Full Text] [Related]
15. Sinusoidal endothelial cell proliferation and expression of angiopoietin/Tie family in regenerating rat liver.
Sato T; El-Assal ON; Ono T; Yamanoi A; Dhar DK; Nagasue N
J Hepatol; 2001 May; 34(5):690-8. PubMed ID: 11434615
[TBL] [Abstract][Full Text] [Related]
16. Vascular endothelial growth factor, placenta growth factor and their receptors in isolated human trophoblast.
Shore VH; Wang TH; Wang CL; Torry RJ; Caudle MR; Torry DS
Placenta; 1997 Nov; 18(8):657-65. PubMed ID: 9364601
[TBL] [Abstract][Full Text] [Related]
17. Analysis of blood vessel maturation processes during cyclic ovarian angiogenesis.
Goede V; Schmidt T; Kimmina S; Kozian D; Augustin HG
Lab Invest; 1998 Nov; 78(11):1385-94. PubMed ID: 9840613
[TBL] [Abstract][Full Text] [Related]
18. Expression of vascular endothelial growth factor receptors in smooth muscle cells.
Ishida A; Murray J; Saito Y; Kanthou C; Benzakour O; Shibuya M; Wijelath ES
J Cell Physiol; 2001 Sep; 188(3):359-68. PubMed ID: 11473363
[TBL] [Abstract][Full Text] [Related]
19. Angiogenic growth factor messenger ribonucleic acids in uterine natural killer cells.
Li XF; Charnock-Jones DS; Zhang E; Hiby S; Malik S; Day K; Licence D; Bowen JM; Gardner L; King A; Loke YW; Smith SK
J Clin Endocrinol Metab; 2001 Apr; 86(4):1823-34. PubMed ID: 11297624
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-1 beta upregulates cardiac expression of vascular endothelial growth factor and its receptor KDR/flk-1 via activation of protein tyrosine kinases.
Maruyama K; Mori Y; Murasawa S; Masaki H; Takahashi N; Tsutusmi Y; Moriguchi Y; Shibazaki Y; Tanaka Y; Shibuya M; Inada M; Matsubara H; Iwasaka T
J Mol Cell Cardiol; 1999 Mar; 31(3):607-17. PubMed ID: 10198191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
